Stan Berenshteyn

Stock Analyst at Wells Fargo

(0)
# 3349
Out of 5,231 analysts
60
Total ratings
46.43%
Success rate
3.23%
Average return
9 Stocks
Name Action Price Target Current % Upside Ratings Updated
Health Catalyst
Maintains: Overweight
13 10
5.66 76.68% 5 Jan 21, 2025
Omnicell
Maintains: Equal-Weight
49 40
44.69 -10.49% 12 Jan 13, 2025
Doximity
Maintains: Equal-Weight
41 43
57.74 -25.53% 9 Jan 13, 2025
American Well
Upgrades: Overweight
15 15
10.99 36.49% 3 Jan 13, 2025
Veeva Systems
Maintains: Overweight
275 285
232.71 22.47% 5 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
6.87 -12.66% 10 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
107 110
109.04 0.88% 8 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10
4.86 105.76% 6 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
28 23
10.37 121.79% 2 Mar 6, 2023